{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:33:41Z","timestamp":1775187221756,"version":"3.50.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02750-0","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:13:13Z","timestamp":1747998793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual roles of long non-coding RNAs in thyroid cancer: regulation of programmed cell death pathways"],"prefix":"10.1007","volume":"42","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok Kumar","family":"Bishoyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anima","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashree","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baneen C.","family":"Gabble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"18","key":"2750_CR1","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1111\/1759-7714.14099","volume":"12","author":"WQ Bao","year":"2021","unstructured":"Bao WQ, et al. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thoracic Cancer. 2021;12(18):2494\u2013503.","journal-title":"Thoracic Cancer"},{"issue":"11","key":"2750_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41574-020-00414-9","volume":"16","author":"CM Kitahara","year":"2020","unstructured":"Kitahara CM, Sosa JAJNRE. Understanding the ever-changing incidence of thyroid cancer. Nat Rev Endocrinol. 2020;16(11):617\u20138.","journal-title":"Nat Rev Endocrinol"},{"key":"2750_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122110","volume":"332","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, et al. Advances and challenges in thyroid cancer: the interplay of genetic modulators, targeted therapies, and AI-driven approaches. Life Sci. 2023;332: 122110.","journal-title":"Life Sci"},{"issue":"3","key":"2750_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"Bible KC, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer: American thyroid association anaplastic thyroid cancer guidelines task force. Thyroid. 2021;31(3):337\u201386.","journal-title":"Thyroid"},{"issue":"10387","key":"2750_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, et al. Thyroid cancer. The Lancet. 2023;401(10387):1531\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X.","journal-title":"The Lancet"},{"issue":"3","key":"2750_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"MJNRC Xing","year":"2013","unstructured":"Xing MJNRC. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184\u201399.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2750_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.30699\/ijp.13.2.125","volume":"13","author":"F Khatami","year":"2018","unstructured":"Khatami F, Tavangar SMJIJOP. A review of driver genetic alterations in thyroid cancers. Iran J Pathol. 2018;13(2):125.","journal-title":"Iran J Pathol"},{"issue":"3","key":"2750_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1210\/en.2006-0921","volume":"148","author":"R Ciampi","year":"2007","unstructured":"Ciampi R, Nikiforov YEJE. RET\/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology. 2007;148(3):936\u201341.","journal-title":"Endocrinology"},{"issue":"4","key":"2750_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ph16040559","volume":"16","author":"K Zhang","year":"2023","unstructured":"Zhang K, et al. Epigenetic targets and their inhibitors in thyroid cancer treatment. Pharmaceuticals. 2023;16(4):559.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"2750_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1385\/EP:15:4:319","volume":"15","author":"YEJEP Nikiforov","year":"2004","unstructured":"Nikiforov YEJEP. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol. 2004;15(4):319\u201327.","journal-title":"Endocr Pathol"},{"issue":"3","key":"2750_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, J.S.J.N.R.G Mattick. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155\u20139.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2750_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2750_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122322","volume":"336","author":"A Mehmandar-Oskuie","year":"2024","unstructured":"Mehmandar-Oskuie A, et al. Molecular mechanism of lncRNAs in pathogenesis and diagnosis of auto-immune diseases, with a special focus on lncRNA-based therapeutic approaches. Life Sci. 2024;336: 122322.","journal-title":"Life Sci"},{"issue":"12","key":"2750_CR14","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.3390\/ijms25126719","volume":"25","author":"P Caban\u00e9","year":"2024","unstructured":"Caban\u00e9 P, et al. Biomarkers in thyroid cancer: emerging opportunities from non-coding RNAs and mitochondrial space. Int J Mol Sci. 2024;25(12):6719.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2750_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12935-023-02867-0","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu Y, Xu XJCCI. Long non-coding RNA signature in colorectal cancer: research progression and clinical application. Cancer Cell Int. 2023;23(1):28.","journal-title":"Cancer Cell Int"},{"key":"2750_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115242","volume":"165","author":"A Mehmandar-Oskuie","year":"2023","unstructured":"Mehmandar-Oskuie A, et al. Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies. Biomed Pharmacother. 2023;165: 115242.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2750_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1534\/genetics.112.146704","volume":"193","author":"JT Kung","year":"2013","unstructured":"Kung JT, Colognori D, Lee JTJG. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651\u201369.","journal-title":"Genetics"},{"issue":"1","key":"2750_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12935-024-03296-3","volume":"24","author":"N Karamali","year":"2024","unstructured":"Karamali N, et al. Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer. Cancer Cell Int. 2024;24(1):104.","journal-title":"Cancer Cell Int"},{"key":"2750_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-0716-1170-8_5","volume":"2257","author":"AH Alkan","year":"2022","unstructured":"Alkan AH, Akg\u00fcl BJMMB, Analysis C. Endogenous miRNA sponges. Methods Mol Biol. 2022;2257:91\u2013104.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2750_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2750_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2750_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","volume":"11","author":"E Koren","year":"2021","unstructured":"Koren E, Fuchs YJCD. Modes of regulated cell death in cancer. Cancer Discov. 2021;11(2):245\u201365.","journal-title":"Cancer Discov"},{"issue":"1","key":"2750_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2750_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, et al. The molecular machinery of regulated cell death. Cell Res. 2019;29(5):347\u201364.","journal-title":"Cell Res"},{"issue":"6","key":"2750_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HYJMC. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904\u201314.","journal-title":"Mol Cell"},{"key":"2750_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10555-017-9715-8","volume":"37","author":"HJ Ferreira","year":"2018","unstructured":"Ferreira HJ, Esteller MJC, Reviews M. Non-coding RNAs, epigenetics, and cancer: tying it all together. Cancer Metastasis Rev. 2018;37:55\u201373.","journal-title":"Cancer Metastasis Rev"},{"key":"2750_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2020.11.048","volume":"501","author":"A Nandwani","year":"2021","unstructured":"Nandwani A, Rathore S, Datta M. LncRNAs in cancer: regulatory and therapeutic implications. Cancer Lett. 2021;501:162\u201371.","journal-title":"Cancer Lett"},{"key":"2750_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","volume":"1008","author":"J Jarroux","year":"2017","unstructured":"Jarroux J, Morillon A, M.J.L.N.C.R.B. Pinskaya,. History, discovery, and classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1\u201346.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"2750_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrcardio.2015.55","volume":"12","author":"Y Devaux","year":"2015","unstructured":"Devaux Y, et al. Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol. 2015;12(7):415\u201325.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2750_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41388-019-1040-y","volume":"39","author":"H Yousefi","year":"2020","unstructured":"Yousefi H, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39(5):953\u201374.","journal-title":"Oncogene"},{"issue":"1","key":"2750_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/life11010056","volume":"11","author":"P Ahmad","year":"2021","unstructured":"Ahmad P, et al. Long non-coding RNAs and their potential roles in the vector\u2013host\u2013pathogen triad. Life. 2021;11(1):56.","journal-title":"Life"},{"key":"2750_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fgene.2020.00150","volume":"11","author":"T Qin","year":"2020","unstructured":"Qin T, Li J, Zhang K-QJFIG. Structure, regulation, and function of linear and circular long non-coding RNAs. Front Genet. 2020;11:150.","journal-title":"Front Genet"},{"issue":"4","key":"2750_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.21037\/atm-20-8191","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, et al. Long non-coding RNA signatures as predictors of prognosis in thyroid cancer: a narrative review. Ann Trans Med. 2021;9(4):359.","journal-title":"Ann Trans Med"},{"issue":"4","key":"2750_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2353\/jmoldx.2006.060080","volume":"8","author":"CC Lubitz","year":"2006","unstructured":"Lubitz CC, et al. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn. 2006;8(4):490\u20138.","journal-title":"J Mol Diagn"},{"issue":"1","key":"2750_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12920-022-01332-7","volume":"15","author":"B Song","year":"2022","unstructured":"Song B, et al. A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs. BMC Med Genom. 2022;15(1):183.","journal-title":"BMC Med Genom"},{"key":"2750_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112050","volume":"133","author":"D Chen","year":"2024","unstructured":"Chen D, et al. Identification of m6A-related lncRNAs LINC02471 and DOCK9-DT as potential biomarkers for thyroid cancer. Int Immunopharmacol. 2024;133: 112050.","journal-title":"Int Immunopharmacol"},{"key":"2750_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.omtn.2022.03.023","volume":"28","author":"C Huang","year":"2022","unstructured":"Huang C, et al. A diagnostic and predictive lncRNA lnc-MPEG1-1 promotes the proliferation and metastasis of papillary thyroid cancer cells by occupying miR-766-5p. Mol Ther Nucleic Acids. 2022;28:408\u201322.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2750_CR38","first-page":"3984463","volume":"2021","author":"F Yang","year":"2021","unstructured":"Yang F, et al. Identification of potential lncRNAs and miRNAs as diagnostic biomarkers for papillary thyroid carcinoma based on machine learning. Int J Endocrinol. 2021;2021(1):3984463.","journal-title":"Int J Endocrinol"},{"key":"2750_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103598","volume":"171","author":"TS Barwal","year":"2022","unstructured":"Barwal TS, et al. A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in thyroid, pancreatic and ovarian cancer. Crit Rev Oncol Hematol. 2022;171: 103598.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2750_CR40","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.2147\/CMAR.S312784","volume":"13","author":"L Li","year":"2021","unstructured":"Li L, et al. Diagnostic value of serum lncRNA HOTAIR combined with Galectin-3 in benign and papillary thyroid carcinoma. Cancer Manag Res. 2021;13:6517\u201325.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"2750_CR41","first-page":"1489","volume":"44","author":"J Tan","year":"2020","unstructured":"Tan J, et al. Overexpression of novel long intergenic non-coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer. Oncol Rep. 2020;44(4):1489\u2013501.","journal-title":"Oncol Rep"},{"key":"2750_CR42","doi-asserted-by":"publisher","first-page":"3651051","DOI":"10.1155\/2020\/3651051","volume":"2020","author":"Y Rao","year":"2020","unstructured":"Rao Y, et al. In silico analysis identifies differently expressed lncRNAs as novel biomarkers for the prognosis of thyroid cancer. Comput Math Methods Med. 2020;2020:3651051.","journal-title":"Comput Math Methods Med"},{"issue":"3","key":"2750_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers16030485","volume":"16","author":"J Karajovic","year":"2024","unstructured":"Karajovic J, et al. Association of HOTAIR, MIR155HG, TERC, miR-155, -196a2, and -146a genes polymorphisms with papillary thyroid cancer susceptibility and prognosis. Cancers (Basel). 2024;16(3):485.","journal-title":"Cancers (Basel)"},{"key":"2750_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155255","volume":"256","author":"R Liu","year":"2024","unstructured":"Liu R, et al. LncRNAs associated with lymph node metastasis in thyroid cancer based on TCGA database. Pathol Res Pract. 2024;256: 155255.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2750_CR45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10238-022-00853-w","volume":"23","author":"YJC Sahin","year":"2023","unstructured":"Sahin YJC, Medicine E. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma. Clin Exp Med. 2023;23(3):841\u201351.","journal-title":"Clin Exp Med"},{"key":"2750_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.748867","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, et al. Identification of Hub lncRNAs along with lncRNA-miRNA-mRNA network for effective diagnosis and prognosis of papillary thyroid cancer. Front Pharmacol. 2021;12: 748867.","journal-title":"Front Pharmacol"},{"key":"2750_CR47","doi-asserted-by":"publisher","first-page":"1610012","DOI":"10.3389\/pore.2022.1610012","volume":"28","author":"JM Yao","year":"2022","unstructured":"Yao JM, et al. A potential nine-lncRNAs signature identification and nomogram diagnostic model establishment for papillary thyroid cancer. Pathol Oncol Res. 2022;28:1610012.","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"2750_CR48","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3892\/or.2020.7919","volume":"45","author":"C Li","year":"2021","unstructured":"Li C, et al. lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b. Oncol Rep. 2021;45(3):1083\u201393.","journal-title":"Oncol Rep"},{"issue":"1","key":"2750_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5603\/ep.97425","volume":"75","author":"X Cao","year":"2024","unstructured":"Cao X, et al. lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p. Endokrynol Pol. 2024;75(1):20\u20136.","journal-title":"Endokrynol Pol"},{"issue":"12","key":"2750_CR50","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41419-021-04386-0","volume":"12","author":"K Guo","year":"2021","unstructured":"Guo K, et al. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p. Cell Death Dis. 2021;12(12):1097.","journal-title":"Cell Death Dis"},{"issue":"24","key":"2750_CR51","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.2174\/0929867330666230522115945","volume":"31","author":"Y Si","year":"2024","unstructured":"Si Y, et al. LINC00891 promotes tumorigenesis and metastasis of thyroid cancer by regulating SMAD2\/3 via EZH2. Curr Med Chem. 2024;31(24):3818\u201333.","journal-title":"Curr Med Chem"},{"issue":"29","key":"2750_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034379","volume":"102","author":"FM Icduygu","year":"2023","unstructured":"Icduygu FM, et al. Upregulation and the clinical significance of KCNQ1OT1 and HAGLROS lncRNAs in papillary thyroid cancer: an observational study. Medicine. 2023;102(29): e34379.","journal-title":"Medicine"},{"key":"2750_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbrc.2023.05.080","volume":"669","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein. Biochem Biophys Res Commun. 2023;669:95\u2013102.","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"2750_CR54","first-page":"20127","volume":"12","author":"R Li","year":"2020","unstructured":"Li R, et al. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression. Aging (Albany NY). 2020;12(20):20127.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"2750_CR55","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/21655979.2021.1882134","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4. Bioengineered. 2021;12(1):496\u2013506.","journal-title":"Bioengineered"},{"issue":"2","key":"2750_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12079-020-00589-w","volume":"15","author":"M Wang","year":"2021","unstructured":"Wang M, et al. Long non-coding RNA DIO3OS\/let-7d\/NF-\u03baB2 axis regulates cells proliferation and metastasis of thyroid cancer cells. J Cell Commun Signal. 2021;15(2):237\u201350.","journal-title":"J Cell Commun Signal"},{"issue":"2","key":"2750_CR57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10528-020-09985-8","volume":"59","author":"Y-L Du","year":"2021","unstructured":"Du Y-L, et al. LncRNA XIST promotes migration and invasion of papillary thyroid cancer cell by modulating MiR-101-3p\/CLDN1 axis. Biochem Genet. 2021;59(2):437\u201352.","journal-title":"Biochem Genet"},{"issue":"9","key":"2750_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19713","volume":"9","author":"J Tang","year":"2023","unstructured":"Tang J, Huang X-XJH. Knockdown of long non-coding RNA SNHG3 inhibits proliferation, migration and invasion of human thyroid cancer via miR-339\u20135p\/GPR62 axis. Heliyon. 2023;9(9): e19713.","journal-title":"Heliyon"},{"issue":"6","key":"2750_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023047995","volume":"33","author":"Z Ma","year":"2023","unstructured":"Ma Z, Wang G, Hu LJCRIEGE. lncRNA EGFEM1P drives the progression of papillary thyroid cancer by regulating miR-6867\u20135p\/CHI3L1 axis. Crit Rev Eukaryot Gene Expr. 2023;33(6):29\u201341.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"5","key":"2750_CR60","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3103\/S0095452723050080","volume":"57","author":"W Wang","year":"2023","unstructured":"Wang W, et al. The long non-coding RNA ENST00000494165 influence papillary thyroid cancer cell proliferation and invasion. Cytol Genet. 2023;57(5):451\u201365.","journal-title":"Cytol Genet"},{"key":"2750_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-1086-5","volume":"20","author":"Z Li","year":"2020","unstructured":"Li Z, et al. TMPO-AS1 promotes cell proliferation of thyroid cancer via sponging miR-498 to modulate TMPO. Cancer Cell Int. 2020;20:1\u201315.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"2750_CR62","doi-asserted-by":"publisher","first-page":"664","DOI":"10.21037\/atm-21-505","volume":"9","author":"Y Guan","year":"2021","unstructured":"Guan Y, et al. LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt\/\u03b2-catenin signaling pathway. Ann Transl Med. 2021;9(8):664.","journal-title":"Ann Transl Med"},{"key":"2750_CR63","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-5725.2023.23.004","author":"P Yun","year":"2023","unstructured":"Yun P, et al. Impact of LncRNA DSCAM-AS1 on the malignant biological behaviors of thyroid cancer cells by regulating the miR-150\u20135p\/BRAF axis. J Practical Med. 2023. https:\/\/doi.org\/10.3969\/j.issn.1006-5725.2023.23.004.","journal-title":"J Practical Med"},{"key":"2750_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110634","volume":"500","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-\u03b21\/Smads signaling pathway. Mol Cell Endocrinol. 2020;500: 110634.","journal-title":"Mol Cell Endocrinol"},{"key":"2750_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153561","volume":"225","author":"D Bai","year":"2021","unstructured":"Bai D, et al. LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151\u20135p\/WNT7A axis. Pathol Res Pract. 2021;225: 153561.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"2750_CR66","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.7150\/jca.42070","volume":"11","author":"Y Duan","year":"2020","unstructured":"Duan Y, et al. lncRNA SNHG3 acts as a novel tumor suppressor and regulates tumor proliferation and metastasis via AKT\/mTOR\/ERK pathway in papillary thyroid carcinoma. J Cancer. 2020;11(12):3492.","journal-title":"J Cancer"},{"issue":"3","key":"2750_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevImmunol.2023050267","volume":"43","author":"T He","year":"2023","unstructured":"He T, et al. m6A writer METTL3-mediated lncRNA LINC01125 prevents the malignancy of papillary thyroid cancer. Crit Rev Immunol. 2023;43(3):43\u201353.","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"2750_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12935-024-03240-5","volume":"24","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. Cancer Cell Int. 2024;24(1):47.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2750_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.amjms.2022.08.005","volume":"365","author":"J Jia","year":"2023","unstructured":"Jia J, et al. LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620\/IRF2BP2 axis. Am J Med Sci. 2023;365(1):73\u201383.","journal-title":"Am J Med Sci"},{"issue":"1","key":"2750_CR70","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13148-023-01622-6","volume":"16","author":"S Wu","year":"2024","unstructured":"Wu S, et al. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428\/KLF9 axis. Clin Epigenetics. 2024;16(1):10.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"2750_CR71","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12033-022-00566-1","volume":"65","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, et al. Correction: overexpression of ST7-AS1 enhances apoptosis and inhibits proliferation of papillary thyroid carcinoma cells via microRNA-181b-5p-dependent inhibition tripartite motif containing 3. Mol Biotechnol. 2023;65(3):491\u20133.","journal-title":"Mol Biotechnol"},{"issue":"1","key":"2750_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12576-021-00793-2","volume":"71","author":"W Sun","year":"2021","unstructured":"Sun W, D.J.T.j.O.P.S. Yin,. Long noncoding RNA CASC7 inhibits the proliferation and migration of papillary thyroid cancer cells by inhibiting miR-34a-5p. J Physiol Sci. 2021;71(1):1\u201310.","journal-title":"J Physiol Sci"},{"key":"2750_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153856","volume":"233","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN\/STAT1 signaling pathway. Pathol Res Practice. 2022;233: 153856.","journal-title":"Pathol Res Practice"},{"key":"2750_CR74","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fonc.2020.00956","volume":"10","author":"W Yang","year":"2020","unstructured":"Yang W, et al. LncRNA NBR2 inhibits the malignancy of thyroid cancer, associated with enhancing the AMPK signaling. Front Oncol. 2020;10:956.","journal-title":"Front Oncol"},{"issue":"4","key":"2750_CR75","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/jcp.29256","volume":"235","author":"L Ji","year":"2020","unstructured":"Ji L, et al. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p\/RGS4 in papillary thyroid cancer. J Cell Physiol. 2020;235(4):3669\u201378.","journal-title":"J Cell Physiol"},{"key":"2750_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101588","volume":"27","author":"M Liu","year":"2023","unstructured":"Liu M, et al. LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p\/IMPA2 axis. Transl Oncol. 2023;27: 101588.","journal-title":"Transl Oncol"},{"issue":"5","key":"2750_CR77","first-page":"2075","volume":"23","author":"X-F Meng","year":"2019","unstructured":"Meng X-F, et al. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(5):2075\u201383.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"2750_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-024-02388-1","volume":"47","author":"J Lu","year":"2024","unstructured":"Lu J, et al. HYPOXIA induces lncRNA HOTAIR for recruiting RELA in papillary thyroid cancer cells to upregulate miR-181a and promote angiogenesis. J Endocrinol Invest. 2024;47(11):1\u201312.","journal-title":"J Endocrinol Invest"},{"key":"2750_CR79","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0221","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer. Endocr Relat Cancer. 2023. https:\/\/doi.org\/10.1530\/ERC-22-0221.","journal-title":"Endocr Relat Cancer"},{"issue":"24","key":"2750_CR80","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1080\/15384101.2021.1995129","volume":"20","author":"D Yi","year":"2021","unstructured":"Yi D, Zhang D, He JJCC. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p\/SIDT2 axis. Cell Cycle. 2021;20(24):2619\u201337.","journal-title":"Cell Cycle"},{"key":"2750_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112251","volume":"146","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. Molecular mechanisms of thyroid cancer: a competing endogenous RNA (ceRNA) point of view. Biomed Pharmacother. 2022;146: 112251.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2750_CR82","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","volume":"35","author":"M Nikolaou","year":"2018","unstructured":"Nikolaou M, et al. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis. 2018;35(4):309\u201318.","journal-title":"Clin Exp Metastasis"},{"key":"2750_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148900","volume":"932","author":"B Naseri","year":"2025","unstructured":"Naseri B, et al. lncRNA PVT1 silencing inhibits gastric cancer cells\u2019 progression via enhancing chemosensitivity to paclitaxel. Gene. 2025;932: 148900.","journal-title":"Gene"},{"issue":"3","key":"2750_CR84","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/1120009X.2022.2082348","volume":"35","author":"Y Fei","year":"2023","unstructured":"Fei Y, Li Y, F.J.J.o.C. Chen,. LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p\/PPP2R1B signalling pathway. J Chemother. 2023;35(3):250\u20138.","journal-title":"J Chemother"},{"issue":"1","key":"2750_CR85","doi-asserted-by":"publisher","first-page":"7183629","DOI":"10.1155\/2020\/7183629","volume":"2020","author":"L Tao","year":"2020","unstructured":"Tao L, et al. lncRNA CASC2 enhances 131I sensitivity in papillary thyroid cancer by sponging miR-155. Biomed Res Int. 2020;2020(1):7183629.","journal-title":"Biomed Res Int"},{"issue":"6","key":"2750_CR86","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41418-023-01157-6","volume":"30","author":"L Shi","year":"2023","unstructured":"Shi L, et al. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ. 2023;30(6):1517\u201332.","journal-title":"Cell Death Differ"},{"issue":"22","key":"2750_CR87","first-page":"13542","volume":"15","author":"M Wang","year":"2023","unstructured":"Wang M, et al. Long non-coding RNA EGOT is associated with 131iodine sensitivity and contributes to thyroid cancer progression by targeting miR-641\/PTEN axis. Aging (Albany NY). 2023;15(22):13542.","journal-title":"Aging (Albany NY)"},{"issue":"23","key":"2750_CR88","first-page":"12224","volume":"24","author":"W Fu","year":"2020","unstructured":"Fu W, et al. CCAT2 contributes to progression and treatment resistance of thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(23):12224\u201331.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2750_CR89","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/biology11060804","volume":"11","author":"MAJB Di Bella","year":"2022","unstructured":"Di Bella MAJB. Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine. Biology. 2022;11(6):804.","journal-title":"Biology"},{"issue":"1","key":"2750_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0831-z","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, et al. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Mol Cancer. 2018;17(1):1\u20139.","journal-title":"Mol Cancer"},{"key":"2750_CR91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.reth.2022.11.005","volume":"22","author":"Q Wu","year":"2023","unstructured":"Wu Q, et al. Cancer stem cell-like cells-derived exosomal lncRNA CDKN2B-AS1 promotes biological characteristics in thyroid cancer via miR-122-5p\/P4HA1 axis. Regen Ther. 2023;22:19\u201329.","journal-title":"Regen Ther"},{"issue":"1","key":"2750_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113268","volume":"419","author":"Q Wu","year":"2022","unstructured":"Wu Q, et al. Cancer stem cell-like cells-derived exosomal CDKN2B-AS1 stabilizes CDKN2B to promote the growth and metastasis of thyroid cancer via TGF-\u03b21\/Smad2\/3 signaling. Exp Cell Res. 2022;419(1): 113268.","journal-title":"Exp Cell Res"},{"issue":"9","key":"2750_CR93","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41419-020-02827-w","volume":"11","author":"W Dai","year":"2020","unstructured":"Dai W, et al. Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma. Cell Death Dis. 2020;11(9):743.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2750_CR94","first-page":"4702855","volume":"2022","author":"B Liu","year":"2022","unstructured":"Liu B, et al. Tumor-derived exosome FGD5-AS1 promotes angiogenesis, vascular permeability, and metastasis in thyroid cancer by targeting the miR-6838-5p\/VAV2 axis. J Oncol. 2022;2022(1):4702855.","journal-title":"J Oncol"},{"issue":"1","key":"2750_CR95","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-021-00407-1","volume":"7","author":"N Jiang","year":"2021","unstructured":"Jiang N, et al. Progress in understanding the role of lncRNA in programmed cell death. Cell Death Discov. 2021;7(1):30.","journal-title":"Cell Death Discov"},{"issue":"24","key":"2750_CR96","doi-asserted-by":"publisher","first-page":"14930","DOI":"10.18632\/aging.205321","volume":"15","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, et al. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206\/HMGA2 expression. Aging (Albany NY). 2023;15(24):14930\u201344.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"2750_CR97","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14715\/cmb\/2024.70.4.12","volume":"70","author":"Y Sang","year":"2024","unstructured":"Sang Y, et al. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206. Cell Mol Biol. 2024;70(4):77\u201384.","journal-title":"Cell Mol Biol"},{"issue":"1","key":"2750_CR98","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41420-021-00551-8","volume":"7","author":"B Zhou","year":"2021","unstructured":"Zhou B, et al. Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression. Cell Death Discov. 2021;7(1):156.","journal-title":"Cell Death Discov"},{"issue":"9","key":"2750_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30331","volume":"10","author":"J Cao","year":"2024","unstructured":"Cao J, Kong W, Xiao X. LINC00115 aggravates thyroid cancer progression by targeting miR-489-3p, which downregulates EVA1A to regulate the Hippo signaling pathway. Heliyon. 2024;10(9): e30331.","journal-title":"Heliyon"},{"key":"2750_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/CMAR.S222085","volume":"12","author":"X Zou","year":"2020","unstructured":"Zou X, et al. Long noncoding RNA LINC00460 modulates MMP-9 to promote cell proliferation, invasion and apoptosis by targeting miR-539 in papillary thyroid cancer. Cancer Manag Res. 2020;12:199\u2013207.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"2750_CR101","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/ijms25031587","volume":"25","author":"C Tous","year":"2024","unstructured":"Tous C, et al. Delving into the role of lncRNAs in papillary thyroid cancer: upregulation of LINC00887 promotes cell proliferation, growth and invasion. Int J Mol Sci. 2024;25(3):1587.","journal-title":"Int J Mol Sci"},{"key":"2750_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153550","volume":"225","author":"L Dong","year":"2021","unstructured":"Dong L, et al. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR. Pathol Res Pract. 2021;225: 153550.","journal-title":"Pathol Res Pract"},{"key":"2750_CR103","doi-asserted-by":"publisher","first-page":"13403","DOI":"10.2147\/CMAR.S283443","volume":"12","author":"QY Lin","year":"2020","unstructured":"Lin QY, et al. LncRNA PVT1 acts as a tumor promoter in thyroid cancer and promotes tumor progression by mediating miR-423-5p-PAK3. Cancer Manag Res. 2020;12:13403\u201313.","journal-title":"Cancer Manag Res"},{"key":"2750_CR104","doi-asserted-by":"publisher","first-page":"9433434","DOI":"10.1155\/2022\/9433434","volume":"2022","author":"Y Deng","year":"2022","unstructured":"Deng Y, Wu J, Li X. lncRNA RUNDC3A-AS1 regulates proliferation and apoptosis of thyroid cancer cells via the miR-151b\/SNRPB axis. Int J Endocrinol. 2022;2022:9433434.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2750_CR105","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/CAD.0000000000001438","volume":"34","author":"Q Du","year":"2023","unstructured":"Du Q, Huang L, Guo W. LncRNA ARAP1-AS1 targets miR-516b-5p\/PDE5A axis to facilitate the progression of thyroid cancer. Anticancer Drugs. 2023;34(6):735\u201346.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"2750_CR106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/or.2021.8015","volume":"45","author":"R Pang","year":"2021","unstructured":"Pang R, Yang S. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR-20b-5p\/SOS1 axis. Oncol Rep. 2021;45(5):64.","journal-title":"Oncol Rep"},{"key":"2750_CR107","first-page":"5946670","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, et al. Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691. Anal Cell Pathol (Amst). 2022;2022:5946670.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"12","key":"2750_CR108","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/cells7120278","volume":"7","author":"Y Chun","year":"2018","unstructured":"Chun Y, Kim J. Autophagy: an essential degradation program for cellular homeostasis and life. Cells. 2018;7(12):278.","journal-title":"Cells"},{"key":"2750_CR109","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.omtn.2020.09.022","volume":"22","author":"Y Qin","year":"2020","unstructured":"Qin Y, et al. ATF2-induced lncRNA GAS8-AS1 promotes autophagy of thyroid cancer cells by targeting the miR-187-3p\/ATG5 and miR-1343-3p\/ATG7 axes. Mol Ther Nucleic Acids. 2020;22:584\u2013600.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"17","key":"2750_CR110","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.1111\/jcmm.16545","volume":"25","author":"D Peng","year":"2021","unstructured":"Peng D, et al. Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy. J Cell Mol Med. 2021;25(17):8148\u201358.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2750_CR111","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/jcmm.14728","volume":"24","author":"X Peng","year":"2020","unstructured":"Peng X, et al. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway. J Cell Mol Med. 2020;24(1):304\u201316.","journal-title":"J Cell Mol Med"},{"key":"2750_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.771556","volume":"11","author":"Y Mu","year":"2022","unstructured":"Mu Y, et al. A comprehensive risk assessment and stratification model of papillary thyroid carcinoma based on the autophagy-related LncRNAs. Front Oncol. 2022;11: 771556.","journal-title":"Front Oncol"},{"issue":"1","key":"2750_CR113","doi-asserted-by":"publisher","first-page":"20230660","DOI":"10.1515\/med-2023-0660","volume":"18","author":"J Hao","year":"2023","unstructured":"Hao J, et al. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma. Open Med (Wars). 2023;18(1):20230660.","journal-title":"Open Med (Wars)"},{"issue":"19","key":"2750_CR114","doi-asserted-by":"publisher","first-page":"9319","DOI":"10.1111\/jcmm.16868","volume":"25","author":"L Feng","year":"2021","unstructured":"Feng L, et al. Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1. J Cell Mol Med. 2021;25(19):9319\u201330.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2750_CR115","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41419-022-04728-6","volume":"13","author":"Y Qin","year":"2022","unstructured":"Qin Y, et al. RBM47\/SNHG5\/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma. Cell Death Dis. 2022;13(3):270.","journal-title":"Cell Death Dis"},{"key":"2750_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.647034","volume":"11","author":"D Wen","year":"2021","unstructured":"Wen D, et al. SNHG9, a papillary thyroid cancer cell exosome-enriched lncRNA, inhibits cell autophagy and promotes cell apoptosis of normal thyroid epithelial cell Nthy-ori-3 through YBOX3\/P21 pathway. Front Oncol. 2021;11: 647034.","journal-title":"Front Oncol"},{"issue":"8","key":"2750_CR117","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Cuproptosis: a new form of programmed cell death. Cell Mol Immunol. 2022;19(8):867\u20138.","journal-title":"Cell Mol Immunol"},{"key":"2750_CR118","doi-asserted-by":"publisher","first-page":"1100909","DOI":"10.3389\/fgene.2023.1100909","volume":"14","author":"Y Shi","year":"2023","unstructured":"Shi Y, et al. Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma. Front Genet. 2023;14:1100909.","journal-title":"Front Genet"},{"issue":"5","key":"2750_CR119","first-page":"995","volume":"52","author":"Y Cai","year":"2023","unstructured":"Cai Y, et al. Potential role of cuproptosis-related Lncrna in prognosis and immunotherapy of thyroid carcinoma. Iran J Public Health. 2023;52(5):995.","journal-title":"Iran J Public Health"},{"issue":"15","key":"2750_CR120","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2217\/bmm-2023-0216","volume":"17","author":"L Liu","year":"2023","unstructured":"Liu L, et al. A novel cuproptosis-related lncRNA prognostic signature in thyroid cancer. Biomark Med. 2023;17(15):643\u201354.","journal-title":"Biomark Med"},{"issue":"5","key":"2750_CR121","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.7150\/ijbs.66917","volume":"18","author":"YB Zuo","year":"2022","unstructured":"Zuo YB, et al. Ferroptosis in cancer progression: role of noncoding RNAs. Int J Biol Sci. 2022;18(5):1829\u201343.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2750_CR122","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12935-022-02674-z","volume":"22","author":"Y Qin","year":"2022","unstructured":"Qin Y, et al. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Cancer Cell Int. 2022;22(1):296.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"2750_CR123","doi-asserted-by":"publisher","first-page":"648","DOI":"10.14740\/wjon1838","volume":"15","author":"JY Zhao","year":"2024","unstructured":"Zhao JY, et al. A new ferroptosis-related long non-coding RNA risk model predicts the prognosis of patients with papillary thyroid cancer. World J Oncol. 2024;15(4):648.","journal-title":"World J Oncol"},{"issue":"2","key":"2750_CR124","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10528-023-10447-0","volume":"62","author":"W Xiao","year":"2024","unstructured":"Xiao W, et al. Predictive role of a novel ferroptosis-related lncRNA pairs model in the prognosis of papillary thyroid carcinoma. Biochem Genet. 2024;62(2):775\u201397.","journal-title":"Biochem Genet"},{"issue":"2","key":"2750_CR125","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, et al. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97\u2013111.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2750_CR126","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, et al. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2750_CR127","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41556-021-00672-3","volume":"23","author":"G Li","year":"2021","unstructured":"Li G, et al. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nat Cell Biol. 2021;23(5):526\u201337.","journal-title":"Nat Cell Biol"},{"key":"2750_CR128","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.2147\/JIR.S456452","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. The prognostic value and potential immune mechanisms of lncRNAs related to immunogenic cell death in papillary thyroid carcinoma. J Inflamm Res. 2024;17:1995\u20132008.","journal-title":"J Inflamm Res"},{"issue":"24","key":"2750_CR129","doi-asserted-by":"publisher","first-page":"22206","DOI":"10.1002\/cam4.6803","volume":"12","author":"H Cai","year":"2023","unstructured":"Cai H, Lv M, Wang TJCM. PANoptosis in cancer, the triangle of cell death. Cancer Med. 2023;12(24):22206\u201323.","journal-title":"Cancer Med"},{"key":"2750_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115696","volume":"168","author":"YJB Xiong","year":"2023","unstructured":"Xiong YJB. The emerging role of PANoptosis in cancer treatment. Biomed Pharmacother. 2023;168: 115696.","journal-title":"Biomed Pharmacother"},{"key":"2750_CR131","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15884","volume":"11","author":"R Li","year":"2023","unstructured":"Li R, et al. Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer. PeerJ. 2023;11: e15884.","journal-title":"PeerJ"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02750-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02750-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02750-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T15:02:14Z","timestamp":1748703734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02750-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":131,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2750"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02750-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"217"}}